» Articles » PMID: 33594114

Case Control Study Comparing the HPV Genome in Patients with Oral Cavity Squamous Cell Carcinoma to Normal Patients Using Metagenomic Shotgun Sequencing

Overview
Journal Sci Rep
Specialty Science
Date 2021 Feb 17
PMID 33594114
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to carry out a case control study comparing the HPV genome in patients with oral cavity squamous cell carcinoma (OC-SCC) to normal patients using metagenomic shotgun sequencing. We recruited 50 OC-SCC cases which were then matched with a control patient by age, gender, race, smoking status and alcohol status. DNA was extracted from oral wash samples from all patients and whole genome shotgun sequencing performed. The raw sequence data was cleaned, reads aligned with the human genome (GRCH38), nonhuman reads identified and then HPV genotypes identified using HPViewer. In the 50 patients with OC-SCC, the most common subsite was tongue in 26 (52%). All patients were treated with primary resection and neck dissection. All but 2 tumors were negative on p16 immunohistochemistry. There were no statistically significant differences between the cases and controls in terms of gender, age, race/ethnicity, alcohol drinking, and cigarette smoking. There was no statistically significant difference between the cancer samples and control samples in the nonhuman DNA reads (medians 4,228,072 vs. 5,719,715, P value = 0.324). HPV was detected in 5 cases (10%) of OC-SCC (genotypes 10, 16, 98) but only 1 tumor sample (genotype 16) yielded a high number of reads to suggest a role in the etiology of OC-SCC. HPV was detected in 4 control patients (genotypes 16, 22, 76, 200) but all had only 1-2 HPV reads per human genome. Genotypes of HPV are rarely found in patients with oral cancer.

Citing Articles

Multinational epidemiological analysis of oral human papillomavirus incidence in 3,137 men.

Mandishora R, Dickey B, Fan W, Sirak B, Isaacs-Soriano K, Rathwell J Nat Microbiol. 2024; 9(11):2836-2846.

PMID: 39424983 DOI: 10.1038/s41564-024-01824-5.


Precision Medicine on the Effects of Microbiota on Head-Neck Diseases and Biomarkers Diagnosis.

Inchingolo A, Malcangi G, Piras F, Palmieri G, Settanni V, Riccaldo L J Pers Med. 2023; 13(6).

PMID: 37373922 PMC: 10304239. DOI: 10.3390/jpm13060933.


Challenges with the use of Xpert HPV as a screening tool for oral HPV among people living with HIV (PLHIV): experiences from Pune, India.

Admase A, Joshi S, Borse R, Deshpande P, Kulkarni V, Khaire S BMC Infect Dis. 2023; 23(1):233.

PMID: 37069524 PMC: 10108491. DOI: 10.1186/s12879-023-08210-2.


Oral Microbiome in Nonsmoker Patients with Oral Cavity Squamous Cell Carcinoma, Defined by Metagenomic Shotgun Sequencing.

Ganly I, Hao Y, Rosenthal M, Wang H, Migliacci J, Huang B Cancers (Basel). 2022; 14(24).

PMID: 36551584 PMC: 9776653. DOI: 10.3390/cancers14246096.


Human Papillomavirus Oral Infection: Review of Methodological Aspects and Epidemiology.

Giuliani E, Rollo F, Dona M, Garbuglia A Pathogens. 2021; 10(11).

PMID: 34832567 PMC: 8625118. DOI: 10.3390/pathogens10111411.

References
1.
Gillison M . Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health. 2008; 43(4 Suppl):S52-60. PMC: 3037092. DOI: 10.1016/j.jadohealth.2008.07.002. View

2.
Munoz N, Castellsague X, Berrington de Gonzalez A, Gissmann L . Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006; 24 Suppl 3:S3/1-10. DOI: 10.1016/j.vaccine.2006.05.115. View

3.
Hanna G, Lau C, Mahmood U, Supplee J, Mogili A, Haddad R . Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer. Oral Oncol. 2019; 95:120-126. DOI: 10.1016/j.oraloncology.2019.06.019. View

4.
Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V . Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region. Head Neck. 2012; 35(5):747-55. DOI: 10.1002/hed.22015. View

5.
Sorbye S, Arbyn M, Fismen S, Jarl Gutteberg T, Mortensen E . HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy. PLoS One. 2011; 6(10):e26022. PMC: 3188582. DOI: 10.1371/journal.pone.0026022. View